Daré Bioscience, Inc. (NASDAQ: DARE) announced that Bayer HealthCare LLC will return all rights to Ovaprene, an investigational hormone-free monthly ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE